Based on SEC filing data. A biotech corporation based in Houston, TX raised $16.1M in Series B equity funding. The company is at the growth stage of development with institutional backing to advance its biotech initiatives.
Get notified the moment Marker Therapeutics, Inc. (MRKR) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.